Esaren Pharmaceuticals Private Limited
About Esaren Pharmaceuticals Private Limited
Data last updated:
Esaren Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 September 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP1997PTC022547. Its GSTIN is 09AAACE6727H1ZK (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Khalda Khanam and Salahuddin.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 90/220 A Iftikharabad, Kanpur, Uttar Pradesh, India – 208001.
As per the financials filed for FY 2024, the company reported a revenue of ₹57.81 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹57,282 (net margin 1%) and EBITDA of ₹2.58 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Esaren Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address90/220 A Iftikharabad, Kanpur, Uttar Pradesh, India – 208001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Esaren Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Esaren Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Esaren Pharmaceuticals Private Limited, buy the company report.
Financials of Esaren Pharmaceuticals Private Limited
FY 2025 filings availableEsaren Pharmaceuticals Private Limited reported revenue of ₹57.81 Lakh (up 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over three years, including 6% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57,282 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Esaren Pharmaceuticals Private Limited, buy the company report.
Board of directors of Esaren Pharmaceuticals Private Limited
Esaren Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khalda Khanam | Director | 01 Sep 1997 | 29 Years 2 Months | Current |
| Salahuddin | Director | 01 Sep 1997 | 29 Years 2 Months | Current |
Peer comparison
Esaren Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esaren Pharmaceuticals Private Limitedthis company | ₹57.81 Lakh (FY 2024) | ₹57,282 | 1% | 6.0% | Kanpur, Uttar Pradesh, India | |
| Kube Pharmaceuticals Private Limited | ₹57.79 Lakh (FY 2025) | 56.0% | Nagpur, Maharashtra, India | |||
| Radius Drug Private Limited | ₹57.77 Lakh (FY 2025) | 91.0% | Csa, Uttar Pradesh, India | |||
| Zatix Pharmaceuticals Private Limited | ₹57.7 Lakh (FY 2024) | 46.0% | New Delhi, Delhi, India | |||
| Beyondinfinite.Com Semiconductor Private Limited | ₹57.59 Lakh (FY 2024) | 61.0% | New Delhi, Delhi, India |
To see the full peer comparison of Esaren Pharmaceuticals Private Limited, buy the company report.
Auditor
Esaren Pharmaceuticals Private Limited is audited by N RAJ & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N RAJ & ASSOCIATES | FY 2023 | 015727C |
Shareholding
The shareholding of Esaren Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Esaren Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Esaren Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Esaren Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Esaren Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACE6727H1ZK | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Esaren Pharmaceuticals Private Limited, buy the company report.
Recent activity
Esaren Pharmaceuticals Private Limited has 4 board changes on record since 1997: 3 appointments and 1 cessation. The latest: Mohammad Rafique ceased to be Director on 17 Feb 2021.
Frequently asked questions
Esaren Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 September 1997 (29+ years old) and is registered under CIN U24232UP1997PTC022547.
Esaren Pharmaceuticals has 2 current directors:
- Khalda Khanam - Director
- Salahuddin - Director
The latest financial statements of Esaren Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Esaren Pharmaceuticals is 09AAACE6727H1ZK, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Esaren Pharmaceuticals is U24232UP1997PTC022547. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esaren Pharmaceuticals was incorporated on 01 September 1997, making it 29+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Esaren Pharmaceuticals by revenue are Kube Pharmaceuticals Private Limited, Radius Drug Private Limited, Zatix Pharmaceuticals Private Limited, Beyondinfinite.Com Semiconductor Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohammad Rafique ceased to be Director on 17 Feb 2021. Mohammad Rafique was appointed as Director on 01 Jul 2007. Khalda Khanam was appointed as Director on 01 Sep 1997. Esaren Pharmaceuticals has 4 board changes on record in total.
The registered office of Esaren Pharmaceuticals is at 90220 A Iftikharabad, Kanpur, Uttar Pradesh, India – 208001.
Esaren Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Esaren Pharmaceuticals is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
